Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

261.22 +1.94 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,979,943
Open 260.00
Bid (Size) 259.80 (1)
Ask (Size) 262.15 (1)
Prev. Close 259.28
Today's Range 259.79 - 262.08
52wk Range 253.30 - 346.85
Shares Outstanding N/A
Dividend Yield 3.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prediction: These 3 Healthcare Stocks Will Soar in 2025
Via The Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
+0.75%
+0.75%
1 Month
-6.12%
-6.12%
3 Month
-18.28%
-18.28%
6 Month
-15.97%
-15.97%
1 Year
-13.84%
-13.84%

More News

Read More
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Analyst Expectations For Amgen's Future
Via Benzinga
Dissecting Our Discipline
Via Talk Markets
Topics Stocks / Equities
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Via Benzinga
Topics Stocks
Exposures US Equities
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
3 Worst Performing Dow Jones Stocks In 2024
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Via Benzinga
Topics ETFs
Spotlight on Amgen: Analyzing the Surge in Options Activity
Via Benzinga
2 Excellent Dividend Stocks to Buy on the Dip
Via The Motley Fool
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
Demystifying Amgen: Insights From 13 Analyst Reviews
Via Benzinga
What's Going On With Amgen Stock On Friday?
Via Benzinga
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
Via Investor's Business Daily
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
Via Investor's Business Daily
10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
Via Investor's Business Daily
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
Via Investor's Business Daily
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Via Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
Via The Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.